Annual total expenses:
$44.07B+$6.98B(+18.82%)Summary
- As of today (August 29, 2025), AZN annual total expenses is $44.07 billion, with the most recent change of +$6.98 billion (+18.82%) on December 31, 2024.
- During the last 3 years, AZN annual total expenses has risen by +$6.51 billion (+17.34%).
- AZN annual total expenses is now at all-time high.
Performance
AZN Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$12.15B+$1.48B(+13.84%)Summary
- As of today (August 29, 2025), AZN quarterly total expenses is $12.15 billion, with the most recent change of +$1.48 billion (+13.84%) on June 30, 2025.
- Over the past year, AZN quarterly total expenses has increased by +$1.14 billion (+10.34%).
- AZN quarterly total expenses is now -8.43% below its all-time high of $13.27 billion, reached on December 31, 2024.
Performance
AZN Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AZN Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.8% | +10.3% |
| 3 y3 years | +17.3% | +16.7% |
| 5 y5 years | +94.6% | +118.1% |
AZN Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.8% | -8.4% | +33.9% |
| 5 y | 5-year | at high | +94.6% | -8.4% | +118.1% |
| alltime | all time | at high | +765.8% | -8.4% | +828.8% |
AZN Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $12.15B(+13.8%) |
| Mar 2025 | - | $10.67B(-19.6%) |
| Dec 2024 | $44.07B(+18.8%) | $13.27B(+9.3%) |
| Sep 2024 | - | $12.14B(+10.2%) |
| Jun 2024 | - | $11.01B(+4.9%) |
| Mar 2024 | - | $10.50B(-5.1%) |
| Dec 2023 | $37.09B(-6.9%) | $11.06B(+9.3%) |
| Sep 2023 | - | $10.12B(+5.4%) |
| Jun 2023 | - | $9.60B(+5.8%) |
| Mar 2023 | - | $9.08B(-11.9%) |
| Dec 2022 | $39.84B(+6.1%) | $10.31B(+10.3%) |
| Sep 2022 | - | $9.34B(-10.3%) |
| Jun 2022 | - | $10.41B(-5.4%) |
| Mar 2022 | - | $11.00B(-11.7%) |
| Dec 2021 | $37.56B(+65.4%) | $12.46B(+8.2%) |
| Sep 2021 | - | $11.52B(+50.2%) |
| Jun 2021 | - | $7.67B(+12.1%) |
| Mar 2021 | - | $6.84B(-0.9%) |
| Dec 2020 | $22.70B(+0.2%) | $6.91B(+13.2%) |
| Sep 2020 | - | $6.10B(+9.5%) |
| Jun 2020 | - | $5.57B(-6.0%) |
| Mar 2020 | - | $5.92B(-12.2%) |
| Dec 2019 | $22.65B(+5.0%) | $6.75B(+6.2%) |
| Sep 2019 | - | $6.35B(+11.5%) |
| Jun 2019 | - | $5.69B(+5.2%) |
| Mar 2019 | - | $5.41B(-12.9%) |
| Dec 2018 | $21.57B(+5.7%) | $6.21B(+17.4%) |
| Sep 2018 | - | $5.29B(-0.7%) |
| Jun 2018 | - | $5.33B(+10.2%) |
| Mar 2018 | - | $4.84B(+8.1%) |
| Dec 2017 | $20.41B(+5.1%) | $4.48B(-19.3%) |
| Sep 2017 | - | $5.55B(+21.3%) |
| Jun 2017 | - | $4.57B(-6.0%) |
| Mar 2017 | - | $4.87B(+30.1%) |
| Dec 2016 | $19.43B(-10.2%) | $3.74B(-20.1%) |
| Sep 2016 | - | $4.68B(-16.4%) |
| Jun 2016 | - | $5.61B(+2.5%) |
| Mar 2016 | - | $5.47B(-2.2%) |
| Dec 2015 | $21.64B(-10.4%) | $5.59B(+8.0%) |
| Sep 2015 | - | $5.17B(-7.8%) |
| Jun 2015 | - | $5.61B(+1.9%) |
| Mar 2015 | - | $5.51B(-21.7%) |
| Dec 2014 | $24.16B(+9.3%) | $7.04B(+10.7%) |
| Sep 2014 | - | $6.36B(+6.5%) |
| Jun 2014 | - | $5.97B(+0.2%) |
| Mar 2014 | - | $5.96B(-21.6%) |
| Dec 2013 | $22.11B(+10.1%) | $7.59B(+53.2%) |
| Sep 2013 | - | $4.95B(-6.4%) |
| Jun 2013 | - | $5.29B(+0.5%) |
| Mar 2013 | - | $5.27B(-9.9%) |
| Dec 2012 | $20.09B(-10.0%) | $5.85B(+13.5%) |
| Sep 2012 | - | $5.15B(+2.3%) |
| Jun 2012 | - | $5.04B(-10.1%) |
| Mar 2012 | - | $5.60B(-20.2%) |
| Dec 2011 | $22.31B(+2.7%) | $7.02B(+47.6%) |
| Sep 2011 | - | $4.76B(-26.6%) |
| Jun 2011 | - | $6.48B(+16.6%) |
| Mar 2011 | - | $5.56B(-22.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $21.72B(-0.4%) | $7.17B(+13.4%) |
| Sep 2010 | - | $6.32B(+10.0%) |
| Jun 2010 | - | $5.74B(+1.6%) |
| Mar 2010 | - | $5.65B(-26.5%) |
| Dec 2009 | $21.81B(-2.9%) | $7.69B(+26.4%) |
| Sep 2009 | - | $6.08B(-0.6%) |
| Jun 2009 | - | $6.12B(+10.3%) |
| Mar 2009 | - | $5.55B(-6.1%) |
| Dec 2008 | $22.46B(+4.6%) | $5.91B(+1.8%) |
| Sep 2008 | - | $5.80B(-7.7%) |
| Jun 2008 | - | $6.29B(+2.3%) |
| Mar 2008 | - | $6.15B(-10.9%) |
| Dec 2007 | $21.46B(+17.6%) | $6.90B(+18.9%) |
| Sep 2007 | - | $5.81B(-0.7%) |
| Jun 2007 | - | $5.85B(+8.2%) |
| Mar 2007 | - | $5.41B(-5.5%) |
| Dec 2006 | $18.26B(+4.6%) | $5.72B(+16.1%) |
| Sep 2006 | - | $4.93B(-0.9%) |
| Jun 2006 | - | $4.97B(+5.0%) |
| Mar 2006 | - | $4.74B(-6.4%) |
| Dec 2005 | $17.45B(+3.4%) | $5.06B(+15.0%) |
| Sep 2005 | - | $4.40B(-10.1%) |
| Jun 2005 | - | $4.90B(+2.1%) |
| Mar 2005 | - | $4.80B(-1.6%) |
| Dec 2004 | $16.88B(+13.7%) | $4.88B(+16.8%) |
| Sep 2004 | - | $4.17B(-9.7%) |
| Jun 2004 | - | $4.62B(+0.3%) |
| Mar 2004 | - | $4.61B(+8.6%) |
| Dec 2003 | $14.84B(+7.3%) | $4.24B(+5.7%) |
| Sep 2003 | - | $4.01B(+4.7%) |
| Jun 2003 | - | $3.83B(-2.2%) |
| Mar 2003 | - | $3.92B(-12.4%) |
| Dec 2002 | $13.84B(+12.3%) | $4.47B(+16.0%) |
| Sep 2002 | - | $3.86B(+6.0%) |
| Jun 2002 | - | $3.64B(+5.1%) |
| Mar 2002 | - | $3.46B(-5.9%) |
| Dec 2001 | $12.32B(-9.7%) | $3.68B(+14.4%) |
| Sep 2001 | - | $3.22B(-3.3%) |
| Jun 2001 | - | $3.33B(+4.8%) |
| Mar 2001 | - | $3.17B(+94.2%) |
| Dec 2000 | $13.64B(+16.6%) | $1.64B(-52.7%) |
| Sep 2000 | - | $3.46B(-25.5%) |
| Jun 2000 | - | $4.64B(+46.6%) |
| Mar 2000 | - | $3.17B(+142.0%) |
| Dec 1999 | $11.70B(+31.6%) | $1.31B(-61.2%) |
| Sep 1999 | - | $3.37B(-4.0%) |
| Jun 1999 | - | $3.51B(+40.2%) |
| Dec 1998 | $8.89B(+31.2%) | - |
| Jun 1998 | - | $2.51B(+52.9%) |
| Dec 1997 | $6.77B(-7.4%) | - |
| Dec 1996 | $7.32B(+24.3%) | - |
| Dec 1995 | $5.89B(+1.3%) | - |
| Jun 1995 | - | $1.64B |
| Dec 1994 | $5.81B(+4.7%) | - |
| Dec 1993 | $5.55B(+9.0%) | - |
| Dec 1992 | $5.09B(-16.3%) | - |
| Dec 1991 | $6.08B(+0.7%) | - |
| Dec 1990 | $6.04B | - |
FAQ
- What is AstraZeneca PLC annual total expenses?
- What is the all time high annual total expenses for AstraZeneca PLC?
- What is AstraZeneca PLC annual total expenses year-on-year change?
- What is AstraZeneca PLC quarterly total expenses?
- What is the all time high quarterly total expenses for AstraZeneca PLC?
- What is AstraZeneca PLC quarterly total expenses year-on-year change?
What is AstraZeneca PLC annual total expenses?
The current annual total expenses of AZN is $44.07B
What is the all time high annual total expenses for AstraZeneca PLC?
AstraZeneca PLC all-time high annual total expenses is $44.07B
What is AstraZeneca PLC annual total expenses year-on-year change?
Over the past year, AZN annual total expenses has changed by +$6.98B (+18.82%)
What is AstraZeneca PLC quarterly total expenses?
The current quarterly total expenses of AZN is $12.15B
What is the all time high quarterly total expenses for AstraZeneca PLC?
AstraZeneca PLC all-time high quarterly total expenses is $13.27B
What is AstraZeneca PLC quarterly total expenses year-on-year change?
Over the past year, AZN quarterly total expenses has changed by +$1.14B (+10.34%)